TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
2,852,337
|
2,515,734
|
2,392,534 |
Financial expenses |
3,361
|
21,263
|
1,010 |
Earnings before taxes |
511,580
|
473,177
|
393,300 |
EBITDA |
651,171
|
635,335
|
520,167 |
Total assets |
4,233,220
|
3,882,799
|
3,412,186 |
Current assets |
3,027,669
|
2,720,983
|
2,404,640 |
Current liabilities |
398,994
|
391,765
|
309,344 |
Equity capital |
3,619,099
|
3,299,092
|
2,910,781 |
- share capital |
120
![]() |
120
|
100 |
Employees (average) |
9,734
|
8,336
|
8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
85.5%
|
85.0%
|
85.3% |
Turnover per employee |
293
|
302
|
294 |
Profit as a percentage of turnover |
17.9%
|
18.8%
|
16.4% |
Return on assets (ROA) |
12.2%
|
12.7%
|
11.6% |
Current ratio |
758.8%
|
694.5%
|
777.3% |
Return on equity (ROE) |
14.1%
|
14.3%
|
13.5% |
Change turnover |
540,379
|
167,509
|
88,160 |
Change turnover % |
23%
|
7%
|
4% |
Chg. No. of employees |
1,398
|
195
|
233 |
Chg. No. of employees % |
17%
|
2%
|
3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.